Your browser doesn't support javascript.
loading
Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort.
Rulle, Undine; Tsourti, Zoi; Casanova, Ruben; Deml, Karl-Friedrich; Verbeken, Eric; Thunnissen, Erik; Warth, Arne; Cheney, Richard; Sejda, Aleksandra; Speel, Ernst Jan; Madsen, Line Bille; Nonaka, Daisuke; Navarro, Atilio; Sansano, Irene; Marchetti, Antonio; Finn, Stephen P; Monkhorst, Kim; Kerr, Keith M; Haberecker, Martina; Wu, Chengguang; Zygoura, Panagiota; Kammler, Roswitha; Geiger, Thomas; Gendreau, Steven; Schulze, Katja; Vrugt, Bart; Wild, Peter; Moch, Holger; Weder, Walter; Ciftlik, Ata Tuna; Dafni, Urania; Peters, Solange; Bubendorf, Lukas; Stahel, Rolf A; Soltermann, Alex.
Afiliação
  • Rulle U; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Tsourti Z; Frontier Science Foundation Hellas, Athens, Greece.
  • Casanova R; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Deml KF; Institute of Pathology, Cantonal Hospital Münsterlingen, Münsterlingen, Switzerland.
  • Verbeken E; Institute of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Thunnissen E; Institute of Pathology, VU University Medical Centre, Amsterdam, Netherlands.
  • Warth A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Cheney R; Department of Pathology and Anatomical Science, State University of New York at Buffalo, Buffalo, New York.
  • Sejda A; Institute of Pathology, Medical University of Gdansk, Gdansk, Poland.
  • Speel EJ; Institute of Pathology, Maastricht University Medical Centre, Maastricht, Netherlands.
  • Madsen LB; Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark.
  • Nonaka D; Institute of Pathology, Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Navarro A; Institute of Pathology, University General Hospital of Valencia, Valencia, Spain.
  • Sansano I; Institute of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Marchetti A; Institute of Pathology, Ospedale Clinicizzato, Chieti, Italy.
  • Finn SP; Departments of Histopathology and Cancer Molecular Diagnostics, St. James's Hospital and Trinity College, Dublin, Ireland.
  • Monkhorst K; Institute of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Kerr KM; Institute of Pathology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
  • Haberecker M; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Wu C; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Zygoura P; Frontier Science Foundation Hellas, Athens, Greece.
  • Kammler R; Translational Research Coordination - European Thoracic Oncology Platform, Bern, Switzerland.
  • Geiger T; Translational Research Coordination - European Thoracic Oncology Platform, Bern, Switzerland.
  • Gendreau S; Genentech Inc., San Francisco, California.
  • Schulze K; Genentech Inc., San Francisco, California.
  • Vrugt B; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Wild P; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Moch H; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Weder W; Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
  • Ciftlik AT; Lunaphore Technologies SA, EPFL Innovation Park, Lausanne, Switzerland.
  • Dafni U; Frontier Science Foundation Hellas & University of Athens, Athens, Greece.
  • Peters S; Department of Oncology, University Hospital Lausanne, Lausanne, Switzerland.
  • Bubendorf L; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Stahel RA; Clinic and Policlinic of Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Soltermann A; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. Electronic address: alex.soltermann@usz.ch.
J Thorac Oncol ; 13(12): 1851-1863, 2018 12.
Article em En | MEDLINE | ID: mdl-30240851
ABSTRACT

INTRODUCTION:

Phosphatase and tensin homolog (PTEN) loss is frequently observed in NSCLC and associated with both phosphoinositide 3-kinase activation and tumoral immunosuppression. PTEN immunohistochemistry is a valuable readout, but lacks standardized staining protocol and cutoff value.

METHODS:

After an external quality assessment using SP218, 138G6 and 6H2.1 anti-PTEN antibodies, scored on webbook and tissue microarray, the European Thoracic Oncology Platform cohort samples (n = 2245 NSCLC patients, 8980 tissue microarray cores) were stained with SP218. All cores were H-scored by pathologists and by computerized pixel-based intensity measurements calibrated by pathologists.

RESULTS:

All three antibodies differentiated six PTEN+ versus six PTEN- cases on external quality assessment. For 138G6 and SP218, high sensitivity and specificity was found for all H-score threshold values including prospectively defined 0, calculated 8 (pathologists), and calculated 5 (computer). High concordance among pathologists in setting computer-based intensities and between pathologists and computer in H-scoring was observed. Because of over-integration of the human eye, pixel-based computer H-scores were overall 54% lower. For all cutoff values, PTEN- was associated with smoking history, squamous cell histology, and higher tumor stage (p < 0.001). In adenocarcinomas, PTEN- was associated with poor survival.

CONCLUSION:

Calibration of immunoreactivity intensities by pathologists following computerized H-score measurements has the potential to improve reproducibility and homogeneity of biomarker detection regarding epitope validation in multicenter studies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Diagnóstico por Computador / Carcinoma Pulmonar de Células não Pequenas / PTEN Fosfo-Hidrolase / Patologistas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Diagnóstico por Computador / Carcinoma Pulmonar de Células não Pequenas / PTEN Fosfo-Hidrolase / Patologistas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article